C-Myc overexpression enhances proliferation, invasion, metastasis, angiogenesis and immune evasion in pancreatic cancer and c-Myc inhibition attenuates chemoresistance and enhances immunotherapy. Here, MYC is linked to familial pancreatic carcinoma.